AtriCure, Inc. ATRC

Company Overview

AtriCure, Inc. is a medical device company focused on the treatment of atrial fibrillation and the management of left atrial appendage complications. The company operates within the cardiac surgery and electrophysiology segments of the broader medical technology industry. Its core offerings include surgical ablation systems, minimally invasive devices, and appendage management products used primarily in hospital settings by cardiothoracic surgeons and electrophysiologists.

The company’s primary revenue drivers are its Ablation Products and Left Atrial Appendage Management (LAAM) Products, which are designed to address unmet clinical needs in the treatment of cardiac arrhythmias and stroke prevention. AtriCure is positioned as a specialized provider with a strong focus on surgical solutions, differentiating itself from competitors that emphasize catheter-based approaches. Founded in 2000, the company has evolved from a single-product developer into a diversified cardiac surgery platform through product innovation, regulatory approvals, and targeted acquisitions.